Form 8-K - Current report:
SEC Accession No. 0001193125-25-154336
Filing Date
2025-07-02
Accepted
2025-07-02 07:00:26
Documents
12
Period of Report
2025-06-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d79904d8k.htm   iXBRL 8-K 29893
  Complete submission text file 0001193125-25-154336.txt   144167

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tcrx-20250630.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrx-20250630_lab.xml EX-101.LAB 17977
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrx-20250630_pre.xml EX-101.PRE 11253
14 EXTRACTED XBRL INSTANCE DOCUMENT d79904d8k_htm.xml XML 3637
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 251098311
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)